These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 603996)

  • 1. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
    Bowers MB; Heninger GR
    Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness.
    Ashcroft GW; Blackburn IM; Eccleston D; Glen AI; Hartley W; Kinloch NE; Lonergan M; Murray LG; Pullar IA
    Psychol Med; 1973 Aug; 3(3):319-25. PubMed ID: 4147078
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebrospinal fluid amine metabolites in affective illness and schizophrenia: clinical and pharmacological studies.
    Goodwin FK; Post RM
    Psychopharmacol Commun; 1975; 1(6):641-53. PubMed ID: 1224017
    [No Abstract]   [Full Text] [Related]  

  • 4. Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes.
    Bowers MB
    J Nerv Ment Dis; 1974 May; 158(5):325-30. PubMed ID: 4823933
    [No Abstract]   [Full Text] [Related]  

  • 5. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders.
    Vestergaard P; Sørensen T; Hoppe E; Rafaelsen OJ; Yates CM; Nicolaou N
    Acta Psychiatr Scand; 1978 Jul; 58(1):88-96. PubMed ID: 696380
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrospinal fluid levels of MHPG in affective disorders.
    Wilk S; Shopsin B; Gershon S; Suhl M
    Nature; 1972 Feb; 235(5339):440-1. PubMed ID: 4553689
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorometric measurement of 5-hydroxyindoleacetic acid (5HIAA) and tryptophan in human CSF: effects of high doses of probenecid.
    Bowers MB
    Biol Psychiatry; 1974 Aug; 9(1):93-8. PubMed ID: 4457119
    [No Abstract]   [Full Text] [Related]  

  • 8. CSF monoamine metabolites during treatment with mianserin or amitryptyline.
    Mendlewicz J; Pinder RM; Stulemeijer SM; van Dorth R
    Adv Biochem Psychopharmacol; 1982; 32():249-56. PubMed ID: 6178263
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 10. CSF monoamine metabolites in depression and schizophrenia.
    Berger PA; Faull KF; Kilkowski J; Anderson PJ; Kraemer H; Davis KL; Barchas JD
    Am J Psychiatry; 1980 Feb; 137(2):174-80. PubMed ID: 7352572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.
    Bowers MB; Study RE
    Psychopharmacology (Berl); 1979 Mar; 62(1):17-22. PubMed ID: 220657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
    Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
    [No Abstract]   [Full Text] [Related]  

  • 13. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
    Kirstein L; Bowers MB; Heninger G
    Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
    Post RM; Goodwin FK
    Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
    [No Abstract]   [Full Text] [Related]  

  • 15. Amine metabolites in cerebrospinal fluid from Huntigton's chorea patients treated with lithium.
    Vestergaard P; Yates CM
    Clin Chim Acta; 1978 Jul; 87(2):297-9. PubMed ID: 148982
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients.
    Fyrö B; Petterson U; Sedvall G
    Psychopharmacologia; 1975 Oct; 44(1):99-103. PubMed ID: 1105629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women.
    Banki CM
    Eur J Clin Pharmacol; 1977 Apr; 11(4):311-5. PubMed ID: 862653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
    Abrams R; Essman WB; Taylor MA; Fink M
    Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of carbamazepine in affective illness: a preliminary report.
    Ballenger JC; Post RM
    Commun Psychopharmacol; 1978; 2(2):159-75. PubMed ID: 352607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.